145 related articles for article (PubMed ID: 3535496)
21. [Interferon therapy in hematological malignancies].
Aderka D; Levo Y
Harefuah; 1986 Apr; 110(8):400-5. PubMed ID: 3527891
[No Abstract] [Full Text] [Related]
22. Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis.
Talpaz M; Kurzrock R; Kantarjian H; O'Brien S; Gutterman JU
Am J Med; 1989 May; 86(5):554-8. PubMed ID: 2712063
[TBL] [Abstract][Full Text] [Related]
23. Clinical use of biologic response modifiers in cancer treatment: an overview. Part I. The interferons.
Balmer CM
DICP; 1990; 24(7-8):761-8. PubMed ID: 1695795
[TBL] [Abstract][Full Text] [Related]
24. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service.
Kantarjian HM; Smith TL; O'Brien S; Beran M; Pierce S; Talpaz M
Ann Intern Med; 1995 Feb; 122(4):254-61. PubMed ID: 7825760
[TBL] [Abstract][Full Text] [Related]
25. [Effect of human lymphoblast interferon in adult T-cell leukemia and non-Hodgkin's lymphoma].
Kamihira S; Soda H; Kinoshita K; Ichimaru M
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2188-93. PubMed ID: 6605114
[TBL] [Abstract][Full Text] [Related]
26. Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies. Proceedings of a satellite symposium at the Third International Conference on Malignant Lymphoma. Lugano June 1987.
Cancer Treat Rev; 1988 Jan; 15 Suppl A():1-65. PubMed ID: 3342416
[No Abstract] [Full Text] [Related]
27. The role of interferon in the treatment of hairy cell leukemia.
Ratain MJ; Vardiman JW; Golomb HM
Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
[TBL] [Abstract][Full Text] [Related]
28. Update on the antitumor activity of alpha interferon.
Quesda JR
Oncology (Williston Park); 1988 Mar; 2(3):49-54. PubMed ID: 3079324
[TBL] [Abstract][Full Text] [Related]
29. Preclinical biology of alpha interferons.
Trotta PP
Semin Oncol; 1986 Sep; 13(3 Suppl 2):3-12. PubMed ID: 3532333
[TBL] [Abstract][Full Text] [Related]
30. Clinical trials in hairy cell leukemia. Current status and future directions.
Cheson BD; Martin A
Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204
[TBL] [Abstract][Full Text] [Related]
31. Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial.
Horning SJ; Merigan TC; Krown SE; Gutterman JU; Louie A; Gallagher J; McCravey J; Abramson J; Cabanillas F; Oettgen H
Cancer; 1985 Sep; 56(6):1305-10. PubMed ID: 4027869
[TBL] [Abstract][Full Text] [Related]
32. Phase I-II study of recombinant alpha-2 interferon against advanced leukemia and lymphoma in children.
Ochs J; Abromowitch M; Rudnick S; Murphy SB
J Clin Oncol; 1986 Jun; 4(6):883-7. PubMed ID: 3458876
[TBL] [Abstract][Full Text] [Related]
33. The role of interferon in cancer therapy: a current perspective.
Goldstein D; Laszlo J
CA Cancer J Clin; 1988; 38(5):258-77. PubMed ID: 2458171
[TBL] [Abstract][Full Text] [Related]
34. Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.
O'Connell MJ; Colgan JP; Oken MM; Ritts RE; Kay NE; Itri LM
J Clin Oncol; 1986 Feb; 4(2):128-36. PubMed ID: 3511183
[TBL] [Abstract][Full Text] [Related]
35. Alpha-interferon treatment for adult T cell leukemia: low levels of circulating alpha-interferon and it's clinical effectiveness.
Saigo K; Shiozawa S; Shiozawa K; Wakuya J; Ueda K; Yamaguchi N; Shibata H; Masaoka T
Blut; 1988 Feb; 56(2):83-6. PubMed ID: 3257708
[TBL] [Abstract][Full Text] [Related]
36. In vitro induction of proteins by alpha-interferon in hairy cell leukemia.
Samuels BL; Golomb HM; Brownstein BH
Cancer Res; 1986 Aug; 46(8):4151-5. PubMed ID: 3731082
[TBL] [Abstract][Full Text] [Related]
37. Interferon studies in the treatment of patients with leukemia.
Schiffer CA
Semin Oncol; 1991 Oct; 18(5 Suppl 7):1-6. PubMed ID: 1948122
[TBL] [Abstract][Full Text] [Related]
38. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
39. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):13-7. PubMed ID: 3589701
[TBL] [Abstract][Full Text] [Related]
40. Interferons in the treatment of multiple myeloma.
Cooper MR; Welander CE
Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
